Global Single-Use Bioreactor Market Report and Forecast 2024-2032

Global Single-Use Bioreactor Market Outlook

The global single-use bioreactor market size reached a value of more than USD 3.03 billion in 2023. The market is further estimated to grow at a CAGR of 16.10% in the forecast period of 2024-2032.

Rising Utilisation in Mammalian Cell Cultivation to Propel the Market Growth of Single-use Bioreactor

Based on cell type, the increasing demand for single-use bioreactors in mammalian cell cultivation is driving the market growth. Advancements in mammalian cell cultivation for medicinal innovations are also boosting the requirement for robust, flexible, and cost-effective bioreactor systems, thereby bolstering the single-use bioreactor market growth. 

Single-use bioreactors are playing a critical role in overcoming various challenges in medical applications like eliminating nutrient gradient formation, establishing uniform culture medium aeration, preventing microbial contamination, and reducing hydrodynamic shear, among others. Additionally, the single-use bioreactor’s software enables the monitoring or adjustment of culture conditions in real-time. Several initiatives taken by the market players to provide single-use bioreactors that are ideal for mammalian cell culture are likely to aid the market over the forecast period.

North America to Account for a Substantial Share in the Single-use Bioreactor Market

The strong presence of leading pharmaceutical and biopharmaceutical companies in North America and the growing research activities to develop novel products are fuelling the market growth of single-use bioreactor. Meanwhile, the Asia Pacific region is expected to significantly contribute to the market owing to the rising investments in life science research, the high availability of skilled labour, and the expanding number of contract research organisations.

Market Segmentation

A bioreactor is a device or apparatus that supports a biologically active environment for growing organisms like yeast, bacteria, animal cells, and others. A single-use bioreactor, also known as a disposable bioreactor, uses single-use bags in place of a cultured vessel. The lining in contact with the cell is plastic, which is supported by a more permanent structure.

The market for single-use bioreactor, by product type, is divided into:

• Single-Use Bioreactor Systems

• Media Bags

• Filtration Assemblies

• Others

Based on cell type, the market is segmented into:

• Mammalian Cell

• Bacteria

• Yeast

• Others

On the basis of molecule type, the market is classified into:

• Vaccines

• Monoclonal Antibodies

• Stem Cells

• Recombinant Proteins

• Others

Based on end use, the market is segmented into:

• Pharmaceutical and Biopharmaceutical Industries

• Contract Research Organisations (CRO)

• Others

The regional markets for single-use bioreactor can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Expanding Biopharmaceutical Sector to Drive the Market Growth of Single-Use Bioreactor

The rising trend of multi-drug facilities and the growing use of single-use bioreactors in the pharmaceutical and biopharmaceutical sectors owing to their multiple advantages are supporting the market growth. Moreover, the increasing investments in research and development to develop drugs for effective clinical treatment of diseases, like cancers and metabolic disorders, are driving the single-use bioreactor market demand.

Single-use bioreactors utilise lower amounts of water and eradicate the need to clean and sterilise the cell culture vessel, thereby eliminating the time, labour, expense, and usage of environmentally hazardous chemicals in the cleaning process. As single-use bioreactors are more mobile and arranged on skids as compared to traditional bioreactors., they offer reduced turn-around time between production batches and enhance flexibility in process set-up. 

The expanding biopharmaceutical manufacturing sector is positively influencing the single-use bioreactor market development. Advancements in single‑use bioreactors technology for meeting large‑scale process capacities, as well as improving design and automation levels of single‑use bioreactors are likely to favour the market. The development of robust single‑use sensor technologies is expected to further stimulate the market over the forecast period.

Key Players in the Global Market for Single-Use Bioreactor

The report gives a detailed analysis of the following key players in the global single-use bioreactor market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Sartorius AG

• Distek Inc.

• Eppendorf SE

• Cytiva

• Merck KGaA

• Pall Corporation

• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

Single-Use Bioreactor  Drugs Market Report Snapshots

Single-Use Bioreactor  Drugs Market Size

Single-Use Bioreactor  Drugs Companies